Efficacy and Safety Study of Antibiotic Treatment to Treat Hip Prosthetic Joint Infection

PHASE2UnknownINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions
Hip Prosthetic Joint Infection
Interventions
DRUG

VANCOMYCIN

DRUG

CEFTRIAXONE

DRUG

CLINDAMYCIN

DRUG

SULFAMETHOXAZOLE AND TRIMETHOPRIM (CO-TRIMOXAZOLE)

DRUG

FLUOROQUINOLONE

DRUG

LINEZOLID

DRUG

RIFAMPIN

Trial Locations (9)

28007

NOT_YET_RECRUITING

Hospital General Universitario Gregorio Maranon, Madrid

33100

RECRUITING

Azienda Opedaliera Universitaria San Maria della Misericordia, Udine

37044

RECRUITING

CHRU de Tours, Tours

59208

NOT_YET_RECRUITING

CH de Tourcoing, Tourcoing

67400

RECRUITING

Centre de Chirurgie Orthopédique et de la Main, Strasbourg

Unknown

RECRUITING

CHU de Nantes, Nantes

NOT_YET_RECRUITING

CHU de Poitiers, Poitiers

08036

RECRUITING

Hospital Clinic of Barcelona, Barcelona

07198

NOT_YET_RECRUITING

Hospital Son Llatzer, Palma de Mallorca

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Pfizer

INDUSTRY

collaborator

International Clinical Trials Association

OTHER

lead

University Hospital, Tours

OTHER

NCT01757236 - Efficacy and Safety Study of Antibiotic Treatment to Treat Hip Prosthetic Joint Infection | Biotech Hunter | Biotech Hunter